NPs play a critical role in expanding access to buprenorphine treatment for Medicaid patients with OUD. Similar patient complexity across providers supports the potential for broader NP involvement in OUD care. The lack of change after X-waiver removal suggests that other factors influence prescribing practices.
Turi et al. (Wed,) studied this question.